This will be a great boost to Pfizer in the United Kingdom...

With perfect timing just before the start of World No Tobacco Day the United Kingdom’s National Institute for Clinical Excellence has come out saying that they actively support the smoking cessation drug Champix that is made by the drug company Pfizer.

The National Institute for Clinical Excellence said that they felt that Champix was much better than the array of different nicotine replacement patches and therapies and even said that in their opinion Champix was more effective than the Zyban drug made by GlaxoSmithKline. This will be a great boost to Pfizer in the United Kingdom and the announcement could not have come at a better time for them as awareness of smoking issues are at their height this week. Champix has really revolutionised the anti smoking drug market in that it works in a completely novel way to any other smoking cessation drug.

Champix is a drug that works on the brain receptors to prevent the cravings that smokers experience when they give up and the drug must be taken for two weeks before they decide to take the plunge and stop smoking. Champix is generally well received by all patients however some people complain that they feel sick when they take it. This problem can normally be sorted out by eating before you take the drug.

In America the Champix anti smoking drug is called Chantix and while we can not be certain about this at Ukmedix News we reckon it has something to do with the regulations that govern the names of drugs in America which say that they must not give the idea that they can do anything for you from the name alone. The word Champix is similar to ‘champion’ and that is probably why the Food and Drug Administration required that the name was changed to Chantix.